• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Enzymotec Ltd

+ Add to Watchlist

ENZY:US

8.9600 USD 0.0900 0.99%

As of 10:49:01 ET on 08/20/2014.

Snapshot for Enzymotec Ltd (ENZY)

Open: 9.0100 Day's Range: 8.9000 - 9.2240 Volume: 31,667
Previous Close: 9.0500 52wk Range: 8.7700 - 35.1200 1-Yr Rtn: -

Stock Chart for ENZY

No chart data available.
  • ENZY:US 8.9300
  • 1D
  • 1M
  • 1Y
9.0500
Interactive ENZY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENZY

Current P/E Ratio (ttm) 17.4038
Estimated P/E(12/2014) 29.3831
Relative P/E vs. SPX 0.9760
Earnings Per Share (USD) (ttm) 0.5200
Est. EPS (USD) (12/2014) 0.3080
Est. PEG Ratio 1.3457
Market Cap (M USD) 196.54
Shares Outstanding (M) 21.72
30 Day Average Volume 139,621
Price/Book (mrq) 1.5630
Price/Sale (ttm) 1.1208
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENZY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENZY

Enzymotec Ltd. produces specialty chemicals. The Company develops and manufactures nutritional ingredients and medical foods. Enzymotec operates in both the nutrition and pharmaceutical markets and has a diverse range of products that spans the human life cycle, from infancy to adulthood.

Steve DubinChairmanYoav DoppeltVice Chairman
Ariel KatzPresident/CEO/Head:Vaya PharmaYoni TwitoChief Operations Officer
More Company Profile & Key Executives for ENZY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil